Article information
Full text is only aviable in PDF
Bibliografía
[1.]
World Health Organization. Global tuberculosis control: surveillance, planning, financing. Geneva: WHO; 2006.
[2.]
American Thoracic Society and the Centers for Disease Control and Prevention. Am J Respir Crit Care Med. 2000;161:S221-S47.
[3.]
P.J. Cardona.
New insights on the nature of latent tuberculosis infection and its treatment.
Inflamm Allergy Drug Targets, 6 (2007), pp. 27-39
[4.]
L.G. Wayne.
Dormancy of Mycobacterium tuberculosis and latency of disease.
Eur J Clin Microbiol Infect Dis., 13 (1994), pp. 908-914
[5.]
J.M. Grange.
Immunophysiology and immunopathology of tuberculosis.
Clinical tuberculosis, pp. 113-127
[6.]
T. Ulrichs, S.H. Kaufmann.
New insights into the function of granulomas in human tuberculosis.
J Pathol., 208 (2006), pp. 261-269
[7.]
C.E. Barry III.
Preclinical candidates and targets for tuberculosis therapy.
Curr Opin Investig Drugs., 2 (2001), pp. 198-201
[8.]
W.J. Loesche, N.S. Grossman.
Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment.
Clin Microbiol Rev., 14 (2001), pp. 727-752
[9.]
F. Backhed, R.E. Ley, J.L. Sonnenburg, D.A. Peterson, J.I. Gordon.
Host-bacterial mutualism in the human intestine.
Science, 307 (2005), pp. 1915-1920
[10.]
M.O. Shleeva, K. Bagramyan, M.V. Telkov, G.V. Mukamolova, M. Young, D.B. Kell, et al.
Formation and resuscitation of “nonculturable” cells of Rhodococcus rhodochrous and Mycobacterium tuberculosis in prolonged stationary phase.
Microbiology, 148 (2002), pp. 1581-1591
[11.]
S.A. Rooney, S.L. Young, C.R. Mendelson.
Molecular and cellular processing of lung surfactant.
Faseb J., 8 (1994), pp. 957-967
[12.]
M.S. Gomes, S. Paul, A.L. Moreira, R. Appelberg, M. Rabinovitch, G. Kaplan.
Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages.
Infect Immun., 67 (1999), pp. 3199-3206
[13.]
D.L. Boros.
The cellular immunological aspects of the granulomatous response.
pp. 1-20
[14.]
H. D’Avila, R.C. Melo, G.G. Parreira, E. Werneck-Barroso, H.C. Castro-Faria-Neto, P.T. Bozza.
Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo.
J Immunol., 176 (2006), pp. 3087-3097
[15.]
P. Andersen.
Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis.
Scand J Immunol., 45 (1997), pp. 115-131
[16.]
P.J. Cardona, S. Gordillo, J. Díaz, G. Tapia, I. Amat, A. Pallarés, et al.
Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis.
Infect Immun., 71 (2003), pp. 5845-5854
[17.]
W.B. Brugmann, M.A. Firmani.
Low concentrations of nitric oxide exert a hormetic effect on Mycobacterium tuberculosis in vitro.
J Clin Microbiol., 43 (2005), pp. 4844-4846
[18.]
D. Strickland, U.R. Kees, P.G. Holt.
Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell anergy in vitro associated with inhibition of interleukin-2 receptor signal transduction.
Immunology, 87 (1996), pp. 250-258
[19.]
P. Roth, A. Celada, A. Cruchaud.
Evaluation of human monocyte function in vitro.
Ann Immunol (Paris), 130C (1979), pp. 611-620
[20.]
D. Ordway, M. Henao-Tamayo, I.M. Orme, M. González-Juarrero.
Foamy macrophages within lung granulomas of mice infected with Mycobacterium tuberculosis express molecules characteristic of dendritic cells and antiapoptotic markers of the TNF receptorassociated factor family.
J Immunol., 175 (2005), pp. 3873-3881
[21.]
J.G. Wallace.
The heat resistance of tubercle bacilli in the lungs of infected mice.
Am Rev Respir Dis., 83 (1961), pp. 866-871
[22.]
T.D. Bui, D. Dabdub, S.C. George.
Modeling bronchial circulation with application to soluble gas exchange: description and sensitivity analysis.
J Appl Physiol., 84 (1998), pp. 2070-2088
[23.]
H.L. Rieder.
Epidemiologic basis of tuberculosis control.
International Union Against Tuberculosis and Lund Disease, (1999),
[24.]
N.J. Garton, H. Christensen, D.E. Minnikin, R.A. Adegbola, M.R. Barer.
Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum.
Microbiology, 148 (2002), pp. 2951-2958
[25.]
P.J. Cardona, J. Ruiz-Manzano.
On the nature of Mycobacterium tuberculosis-latent bacilli.
Eur Respir J., 24 (2004), pp. 1044-1051
[26.]
R. Pérez-Padilla, F. Franco-Marina.
The impact of altitude on mortality from tuberculosis and pneumonia.
Int J Tuberc Lung Dis., 8 (2004), pp. 1315-1320
[27.]
M.H. Vargas, M.E. Furuya, C. Pérez-Guzmán.
Effect of altitude on the frequency of pulmonary tuberculosis.
Int J Tuberc Lung Dis., 8 (2004), pp. 1321-1324
[28.]
P.J. Cardona, E. Julián, X. Valles, S. Gordillo, M. Muñoz, M. Luquin, et al.
Production of antibodies against glycolipids from the Mycobacterium tuberculosis cell wall in aerosol murine models of tuberculosis.
Scand J Immunol., 55 (2002), pp. 639-645
[29.]
P.J. Cardona, I. Amat, S. Gordillo, V. Arcos, E. Guirado, J. Díaz, et al.
Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis.
Vaccine, 23 (2005), pp. 1393-1398
[30.]
P.J. Cardona.
RUTI: a new chance to shorten the treatment of latent tuberculosis infection.
Tuberculosis (Edinb), 86 (2006), pp. 273-289
[31.]
P.J. Cardona, I. Amat.
Origen y desarrollo de RUTI, una nueva vacuna terapéutica contra la infección por Mycobacterium tuberculosis.
Arch Bronconeumol, 42 (2006), pp. 25-32
[32.]
E. Guirado, I. Amat, O. Gil, J. Díaz, V. Arcos, N. Cáceres, et al.
Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice.
Microbes Infect., 8 (2006), pp. 1252-1259
Copyright © 2007. Sociedad Española de Neumología y Cirugía Torácica
